Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

BJU International

Volumn 104, Issue 7, 2009, Pages 974-983

  Rosen, Raymond C ^a   Fitzpatrick, John M ^b  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

5 reductase inhibitors; Ejaculation; Ejaculatory disorders; Lower urinary tract symptoms; Sexual function; adrenergic antagonists

Indexed keywords

ALFUZOSIN; DOXAZOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EJACULATION DISORDER; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TREATMENT RESPONSE; AGE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; EJACULATION; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY; PROSTATIC HYPERPLASIA; PROSTATISM; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EJACULATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATISM; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 70049084541     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08503.x     Document Type: Article

References (29)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999 281 : 537 544 (Pubitemid 29081307)
2. Kushiro T, Takahashi A, Saito F et al. Erectile dysfunction and its influence on quality of life in patients with essential hypertension. Am J Hypertens 2005 18 : 427 430
3. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Urology 1994 151 : 54 61
4. Rosen R, Altwein J, Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003 44 : 637 649
5. Vallancien G, Emberton M, Harving N et al. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003 169 : 2257 2261
6. Li M-K, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int 2005 96 : 1339 1354
7. Mondul AM, Rimm EB, Giovannucci E et al. A prospective study of lower urinary tract symptoms and erectile dysfunction. J Urol 2008 179 : 2321 2326
8. Calais Da Silva F, Marquis P, Deschaseaux P et al. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. Eur Urol 1997 31 : 272 280
9. Hoesl CE, Woll EM, Burkart M, Altwein JE. Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome. Eur Urol 2005 47 : 511 517
10. Sells H, Donovan J, Ewings P et al. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 2000 85 : 440 5
11. Rosen RC. Assessment of sexual dysfunction in men with benign prostatic hyperplasia. BJU Int 2006 97 : 29 33
12. Rosen RC, Catania J, Pollack L et al. Male sexual health questionnaire (MSHQ): scale development and psychometric validation. Urology 2004 64 : 777 782
13. Brookes ST, Donovan JL, Peters TJ et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 2002 324 : 1059 1061
14. Giuliano F, Clément P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol 2005 48 : 408 417
15. Schirren C. Biochemical aspects of semen analysis. In Schirren C, Practical Andrology. Berlin : Verlag Brüder Hartmann, Medical-Scientific Publications, 1972 : 28
16. Rui H, Thomassen Y, Oldereid NB, Purvis K. Accessory sex gland function in normal young (20-25 years) and middle-aged (50-55 years) men. J Androl 1986 7 : 93 9
17. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia 2003: chapter 1: diagnosis and treatment recommendations. J Urol 2003 170 : 530 547
18. Muntener M, Aellig S, Kuettel R et al. Sexual function after transurethral resection of the prostate (TURP): Results of an independent prospective multicentre assessment of outcome. Eur Urol 2007 52 : 510 516
19. Hellstrom WJG, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 2006 176 : 1529 1533
20. Hisasue S, Furuya R, Itoh N et al. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol 2006 13 : 1311 1316
21. Giuliano F, Bernabe J, Droupy S et al. A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. BJU Int 2004 93 : 605 608
22. Tambaro S, Ruiu S, Dessi C et al. Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays. J Pharmacol Exp Ther 2005 312 : 710 717
23. Clément P, Bernabé J, Kia HK et al. D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N- propylamino) tetralin in rats. J Pharmacol Exp Ther 2006 316 : 830 834
24. Giuliano F, Clément P, Denys P et al. Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats. BJU Int 2006 98 : 876 879
25. McConnell J, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride and combination therapy on clinical progression of benign prostatic hyperplasia. N Engl J Med 2003 349 : 2387 2398
26. Roehrborn CG, Siami P, Barkin J et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 2008 179 : 616 21
27. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int 2006 97 (Suppl. 34 8
28. Vallancien G, Emberton M, Alcaraz A et al. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real life practice. BJU Int 2008 101 : 847 852
29. Rosen RC, Seftel A, Roehrborn CG. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia. Int J Impot Res 2007 19 : 480 485